Detalhe da pesquisa
1.
The quest for a "diabetic" stent.
Catheter Cardiovasc Interv
; 91(5): 892-893, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29634860
2.
Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT.
Int J Cardiol
; 383: 24-32, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37080466
3.
1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents.
JACC Cardiovasc Interv
; 13(7): 820-830, 2020 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32273094
4.
Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry).
Am J Cardiol
; 127: 1-8, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32418717
5.
Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
Am J Cardiol
; 101(6): 801-6, 2008 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18328844
6.
Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft.
Am J Cardiol
; 98(3): 370-4, 2006 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16860026
7.
Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).
Am J Cardiol
; 98(4): 464-9, 2006 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16893698